|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 64,65 EUR | -6,37% |
|
+3,36% | -0,69% |
| 04/02 | REDCARE PHARMACY : Jefferies handhaaft koopadvies | ZD |
| 29/01 | Danone roept partijen Aptamil-babymelkpoeder terug in Duitsland, volgens brief | RE |
Voorlopige winst- en verliesrekening: Redcare Pharmacy NV
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 968,1 | 1.060 | 1.204 | 1.799 | 2.371 | 2.951 | 3.480 | 4.030 |
| Variatie | - | 9,5% | 13,62% | 49,35% | 31,79% | 24,47% | 17,94% | 15,81% |
| EBITDA 1 | 21,62 | -5 | -8,044 | 53,5 | 33,3 | 65,7 | 109,3 | 159,2 |
| Variatie | - | -123,13% | -60,88% | 765,03% | -37,74% | 97,27% | 66,33% | 45,68% |
| Bedrijfsresultaat (EBIT) 1 | 5,556 | -32,3 | -47,55 | -3,793 | -34,91 | -16,09 | 11,17 | 43,75 |
| Variatie | - | -681,35% | -47,23% | 92,02% | -820,43% | 53,91% | 169,4% | 291,79% |
| Betaalde rente 1 | -15,11 | -11,76 | -15,29 | -15,5 | -16,68 | -13,15 | -12,43 | -11,83 |
| Resultaat voor belastingen (EBT) 1 | -15,93 | -77,88 | -84,12 | -14,35 | -47,83 | -25,21 | 24,22 | 66,18 |
| Variatie | - | -388,85% | -8,01% | 82,94% | -233,38% | 47,29% | 196,07% | 173,25% |
| Nettowinst (verlies) 1 | -16,77 | -74,2 | -77,65 | -12,04 | -45,46 | -18,53 | 4,95 | 46,26 |
| Variatie | - | -342,43% | -4,64% | 84,49% | -277,58% | 59,25% | 126,72% | 834,53% |
| Datum van publicatie | 3/03/21 | 2/03/22 | 7/03/23 | 5/03/24 | 11/03/25 | - | - | - |
1EUR in Miljoen
Geschatte gegevens
Balansprognose: Redcare Pharmacy NV
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuld 1 | -90 | -11 | 188 | 161 | 150 | 140 | 144 | 115 |
| Variatie | - | 87,78% | 1.809,09% | -14,36% | -6,83% | -6,97% | 2,86% | -20,14% |
| Datum van publicatie | 3/03/21 | 2/03/22 | 7/03/23 | 5/03/24 | 11/03/25 | - | - | - |
1EUR in Miljoen
Geschatte gegevens
Verwachte kasstroom: Redcare Pharmacy NV
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 53,34 | 43,16 | 53,52 | 38,22 | 42,15 | 123,3 | 87,9 | 78,2 |
| Variatie | - | -19,08% | 24,02% | -28,59% | 10,28% | 192,51% | -28,71% | -11,03% |
| Vrije kasstroom (FCF) 1 | -35,53 | -31,52 | -82,64 | 23,24 | -20,02 | -18,85 | 20,15 | 55,1 |
| Variatie | - | 11,28% | -162,14% | 128,12% | -186,18% | 5,87% | 206,9% | 173,45% |
| Datum van publicatie | 3/03/21 | 2/03/22 | 7/03/23 | 5/03/24 | 11/03/25 | - | - | - |
1EUR in Miljoen
Geschatte gegevens
Verwachte financiële ratio's: Redcare Pharmacy NV
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
| EBITDA-marge (%) | 2,23% | -0,47% | -0,67% | 2,97% | 1,4% | 2,23% | 3,14% | 3,95% |
| EBIT-marge (%) | 0,57% | -3,05% | -3,95% | -0,21% | -1,47% | -0,55% | 0,32% | 1,09% |
| EBT-marge (%) | -1,65% | -7,35% | -6,98% | -0,8% | -2,02% | -0,85% | 0,7% | 1,64% |
| Nettomarge (%) | -1,73% | -7% | -6,45% | -0,67% | -1,92% | -0,63% | 0,14% | 1,15% |
| FCF-marge (%) | -3,67% | -2,97% | -6,86% | 1,29% | -0,84% | -0,64% | 0,58% | 1,37% |
| Vrije kasstroom/nettoresultaat (%) | 211,87% | 42,49% | 106,43% | -192,97% | 44,05% | 101,74% | 407,09% | 119,12% |
Winstgevendheid | ||||||||
| ROA | -3,5% | -11,24% | -10,27% | -1,38% | -4,49% | -1,44% | 1,41% | 6,25% |
| ROE | -5,1% | -17,65% | -20,17% | -2,75% | -9,04% | -3,38% | 2,79% | 7,82% |
Financiële gezondheid | ||||||||
| Hefboom (schuld/ebitda) | - | - | -23,42x | 3x | 4,52x | 2,13x | 1,32x | 0,72x |
| Schuld/vrije kasstroom | - | - | -2,28x | 6,92x | -7,51x | -7,44x | 7,15x | 2,09x |
Kapitaalintensiteit | ||||||||
| Kapitaaluitgaven/omzet (%) | 5,51% | 4,07% | 4,44% | 2,12% | 1,78% | 4,18% | 2,53% | 1,94% |
| CAPEX / EBITDA (%) | 246,69% | -863,18% | -665,39% | 71,45% | 126,56% | 187,66% | 80,43% | 49,12% |
| CAPEX / FCF (%) | -150,1% | -136,91% | -64,77% | 164,5% | -210,49% | -654,08% | 436,21% | 141,93% |
Bestanddelen per aandeel | ||||||||
| Kasstroom per aandeel 1 | 1,24 | 0,6506 | -1,619 | 3,194 | 1,103 | 3,347 | 4,244 | 6,714 |
| Variatie | - | -47,53% | -348,8% | 297,34% | -65,46% | 203,37% | 26,79% | 58,21% |
| Dividend per aandeel 1 | - | - | - | - | - | - | - | - |
| Variatie | - | - | - | - | - | - | - | - |
| Nettoactief per aandeel 1 | 21,46 | 22,96 | 19,49 | 25,85 | 23,79 | 24,52 | 24,93 | 26,73 |
| Variatie | - | 6,98% | -15,12% | 32,64% | -7,95% | 3,08% | 1,64% | 7,24% |
| WPA 1 | -1,17 | -4,15 | -4,32 | -0,73 | -2,27 | -1,162 | 0,2242 | 2,178 |
| Variatie | - | -254,7% | -4,1% | 83,1% | -210,96% | 48,79% | 119,28% | 871,66% |
| Aantal aandelen (in duizend) | 17.935 | 18.095 | 18.095 | 18.199 | 20.342 | 20.342 | 20.342 | 20.342 |
| Datum van publicatie | 3/03/21 | 2/03/22 | 7/03/23 | 5/03/24 | 11/03/25 | - | - | - |
1EUR
Geschatte gegevens
| 2025 * | 2026 * | |
|---|---|---|
| k/w-verhouding | -55,6x | 288x |
| PBR-ratio | 2,64x | 2,59x |
| EV/omzet | 0,49x | 0,42x |
| Dividendrendement | - | - |
Meer waarderingsratio's
* Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Trader
Trader
Beleggings
Beleggings
Globaal
Globaal
Kwaliteit van de publicaties
Kwaliteit van de publicaties
ESG MSCI
AAA
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
9
Laatste slotkoers
64,65EUR
Gemiddelde koersdoel
131,56EUR
Spread / Gemiddelde doel
+103,49%
Kwartaalomzet - Afwijkingspercentage
Kies jouw editie
Alle financiële informatie op nationaal niveau
